Rare Disease ReportAbeona Gets RMAT Designation for Epidermolysis Bullosa Gene TherapyRare Disease ReportThis morning, Abeona Therapeutics announced that the U.S. Food and Drug Administration (FDA) granted EB-101, its gene therapy for epidermolysis bul… Continue reading
TimeGazetteWorld Cancer Immunotherapy Market 2018 Competitive Analysis | Witness a Pronounce Growth by 2023 | Asserts MRFRDigital JournalThe Global Cancer Immunotherapy Market is expecting growth at a very high rate in the coming future. This is due to… Continue reading
OncLive |
Clinical Data Behind CAR T-Cell Therapies in ALL
OncLive David Maloney, MD, PhD: Yes, I think there’s one practical issue that people always ask me: How to you measure the CAR? Well you don’t actually really have to measure the CAR if you monitor the patient for B-cell recovery. So, if you see CD19-positive … |
|
Human trophoblast stem cells cultured for first time
BioNews Scientists in Japan have cultured human trophoblast stem cells, which form the placenta, for the first time. ‘Trophoblast cells play an essential role in the interactions between the fetus and mother,’ said study author Professor Takahiro Arima of … |
Registrar Daily – Market Research News by Market.Biz (press release) |
Stem Cells: On Your Mark, Get Set, Don’t Go
Genetic Engineering & Biotechnology News Using their Setd7 inhibitor, the scientists were able to prevent immature, transplantable myogenic stem cells (MuSCs) from differentiating so that these cells could continue to divide. Then the scientists implanted the stem cells into the hind leg of … Meet on stem cells heldThe Hindu Worldwide Animal Stem Cell Therapy Market Competition by Market Shares, Growth Rate, Key Players | Analysis and …MilTech Stem Cell Therapy Products MarketsatPRnews (press release) Observer of Press –WhaTech –Registrar Daily – Market Research News by Market.Biz (press release) all 17 news articles » |